Novel Immunotherapy for Neurological Diseases
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 20 September 2025 | Viewed by 1606
Special Issue Editor
Interests: neurodegenerative diseases; neural function; neuroinflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Novel immunotherapeutic approaches for neurological disorders are rapidly evolving in several directions. First, monoclonal antibodies can target specific pathological features, such as beta-amyloid plaques in Alzheimer's disease, to attenuate neuroinflammation. Second, immune checkpoint inhibitors and cellular therapies (e.g., regulatory T cells) aim to enhance the immune system's ability to respond to disease. In addition, cytokine modulation and vaccine development are being explored with the aim of modulating neuroinflammation or inducing immune tolerance. Modulation of the gut microbiome and gene therapy are also seen as potential new therapies. The combination of these approaches may open new pathways for the treatment of neurological diseases and improve the quality of life of patients.
We invite experts to share their valuable insights, new data, and comprehensive systematic evaluations in this emerging and critical field.
Dr. Michel-Edwar Mickael
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- T cells
- immune
- neurological disorders
- Alzheimer's disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
